Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES (ABT)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 01/22 09:37:12 pm
59.34 USD   +0.05%
01/19ABBOTT LABORATO : annual earnings release
01/18 BIOCENTURY - MA : NanoString, Orchard
01/11 ABBOTT LABORATO : ex-dividend day
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales20 24720 40520 85327 19430 19931 995
EBITDA3 8654 8504 9756 9617 9438 677
Operating profit (EBIT)2 8723 9794 1726 0106 9157 635
Pre-Tax Profit (EBT)------
Net income2 2844 4231 4002 2272 8083 003
P/E ratio30,215,440,951,432,933,4
EPS ( $ )1,492,920,941,161,811,79
Dividend per Share ( $ )0,900,981,041,071,101,15
Yield2,00%2,18%2,71%1,80%1,84%1,93%
Reference price ( $ )45.0244.9138.4159.5759.5759.57
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt3 7822 8763 23117 25814 71411 494
Finance------
Operating income (EBITDA)3 8654 8504 9756 9617 9438 677
Leverage
(Debt/EBITDA)
0,98x0,59x0,65x2,48x1,85x1,32x
Capital Expenditure1 0771 1101 1211 1071 2781 261
Book Value Per Share (BVPS)14,3 $14,4 $13,9 $16,5 $17,1 $18,2 $
Cash Flow per Share2,41 $1,97 $2,16 $2,60 $3,51 $3,96 $
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 103 688 M$ -
Entreprise Value (EV) 120 945 M$ 118 401 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 51,4x 32,9x
Capitalization / Revenue 3,81x 3,43x
EV / Revenue 4,45x 3,92x
EV / EBITDA 17,4x 14,9x
Yield (DPS / Price) 1,80% 1,84%
Price to book (Price / BVPS) 3,62x 3,48x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 22,1% 22,9%
operating Leverage (Delta EBIT / Delta Sales) 1,45x 1,36x
Net Margin (Net Profit / Revenue) 8,19% 9,30%
ROA (Net Profit / Asset) 6,45% 7,25%
ROE (Net Profit / Equities) 16,4% 17,2%
Rate of Dividend 92,4% 60,6%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,07% 4,23%
Cash Flow / Sales 16,6% 20,2%
Capital Intensity (Assets / Sales) 1,27x 1,28x
Financial Leverage (Net Debt / EBITDA) 2,48x 1,85x
EPS & Dividend